Activity
-
Patients prefer convenient options to meet their lipid-lowering goals. These survey results are no surprise; oral therapies are much easier for…
Patients prefer convenient options to meet their lipid-lowering goals. These survey results are no surprise; oral therapies are much easier for…
Liked by Rich Ganz
-
🚨 Programming alert! 🚨 Tune in to CNBC's Fast Money at 4:45pm CT this evening to see John Flavin live in-studio as he discusses innovation in…
🚨 Programming alert! 🚨 Tune in to CNBC's Fast Money at 4:45pm CT this evening to see John Flavin live in-studio as he discusses innovation in…
Liked by Rich Ganz
-
Thanks to my friend and fellow entrepreneur Vijen Patel for coming by the Polsky Center at the University of Chicago to meet the team and share…
Thanks to my friend and fellow entrepreneur Vijen Patel for coming by the Polsky Center at the University of Chicago to meet the team and share…
Liked by Rich Ganz
More activity by Rich
-
I’m extremely proud of the entire NewAmsterdam Pharma Corporation team, and thankful to the patients and investigators who made our Phase 3 BROOKLYN…
I’m extremely proud of the entire NewAmsterdam Pharma Corporation team, and thankful to the patients and investigators who made our Phase 3 BROOKLYN…
Liked by Rich Ganz
-
Thank you Starczynowski Research Lab at Cincinnati Children's Hospital for your support for the past 5 years! This period has been both wonderful and…
Thank you Starczynowski Research Lab at Cincinnati Children's Hospital for your support for the past 5 years! This period has been both wonderful and…
Liked by Rich Ganz
-
Thank you BE NKY Growth Partnership for the tour of our new Covington Life Sciences Partners lab space. The office views will be incredible for our…
Thank you BE NKY Growth Partnership for the tour of our new Covington Life Sciences Partners lab space. The office views will be incredible for our…
Liked by Rich Ganz
-
Sharing our first Phase 3 results is an important milestone for all of us at NewAmsterdam Pharma Corporation. But what’s even more energizing is the…
Sharing our first Phase 3 results is an important milestone for all of us at NewAmsterdam Pharma Corporation. But what’s even more energizing is the…
Liked by Rich Ganz
-
Check out the piece Nadya Mason and I wrote in today's Sunday Chicago Tribune about how "The Quantum Revolution is Coming to Illinois" In the…
Check out the piece Nadya Mason and I wrote in today's Sunday Chicago Tribune about how "The Quantum Revolution is Coming to Illinois" In the…
Liked by Rich Ganz
-
Happy Friday! Best way to start the day, especially now as the need is great – please donate if you are able. https://lnkd.in/eesFDXkb
Happy Friday! Best way to start the day, especially now as the need is great – please donate if you are able. https://lnkd.in/eesFDXkb
Liked by Rich Ganz
-
As a leader, being human and showing people you care is powerful. I’ve found in my experience that there’s no substitute for showing people you want…
As a leader, being human and showing people you care is powerful. I’ve found in my experience that there’s no substitute for showing people you want…
Liked by Rich Ganz
-
Washington University in St. Louis Office of Technology Management (Tech Transfer) is excited to launch the Venture Fellows program for Postdocs with…
Washington University in St. Louis Office of Technology Management (Tech Transfer) is excited to launch the Venture Fellows program for Postdocs with…
Liked by Rich Ganz
-
Taylor Harned, PhD of Orange Grove Bio’s #DomainOne Therapeutics team attended the Station 41 Innovation Assembly today in #Birmingham with Erik…
Taylor Harned, PhD of Orange Grove Bio’s #DomainOne Therapeutics team attended the Station 41 Innovation Assembly today in #Birmingham with Erik…
Liked by Rich Ganz
-
Congratulations to Samir Mayekar and the Polsky Center at the University of Chicago, along with Rich Ganz with Orange Grove Bio on the announcment of…
Congratulations to Samir Mayekar and the Polsky Center at the University of Chicago, along with Rich Ganz with Orange Grove Bio on the announcment of…
Liked by Rich Ganz
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Rich Ganz in United States
-
Rich Ganz
US Affinity Growth Leader
-
Rich Ganz
-
Richard Ganz
Special Counsel to the President at Marylhurst University
-
Richard Ganz
Director of Business Development at Validyne Engineering
13 others named Rich Ganz in United States are on LinkedIn
See others named Rich Ganz